Skip to main content
HR 4385 115th Congress House

Responsibility in Drug Advertising Act of 2017

Official title: To amend the Federal Food, Drug, and Cosmetic Act to restrict direct-to-consumer drug advertising.

Introduced: November 14, 2017 Introduced by: DeLauro, Rosa L. Democratic · Connecticut See on congress.gov
Health Drug safety, medical device, and laboratory regulationMarketing and advertisingPrescription drugs
Sign in to write a letter Sign in to watch
This bill died when the 115th Congress ended
It never became law before the 115th Congress (2017–2018) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 17, 2017
Referred to the Subcommittee on Health.
Nov 14, 2017
Referred to the House Committee on Energy and Commerce.
Nov 14, 2017
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action November 17, 2017

Referred to the Subcommittee on Health.

 Plain-English summary Congressional Research Service

Responsibility in Drug Advertising Act of 2017

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit direct-to-consumer advertising of a drug in the first three years after the drug's approval. The Food and Drug Administration may: (1) waive the third year of this prohibition for a drug if direct-to-consumer advertising of the drug would have an affirmative value to public health, or (2) extend the prohibition if the drug has significant adverse health effects.
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 2
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4385: Responsibility in Drug Advertising Act of 2017. 115th Congress. Open America. https://openamerica.io/bill/115-HR-4385/
MLA
"H.R. 4385: Responsibility in Drug Advertising Act of 2017." 115th Congress, 2026, Open America, https://openamerica.io/bill/115-HR-4385/.
Bluebook (legal)
H.R. 4385, 115th Cong. (2026), https://openamerica.io/bill/115-HR-4385/.
Markdown link
[H.R. 4385: Responsibility in Drug Advertising Act of 2017](https://openamerica.io/bill/115-HR-4385/)
Report a problem